Structural Heart Disease

>

Latest News

Sacubtril/Valsartan Lowers Risk of Cardiotoxicity Linked to Chemotherapy | Image Credit: American Heart Association
Sacubtril/Valsartan Lowers Cardiotoxicity Risk Linked to Chemotherapy

November 18th 2024

Sacubitril/valsartan reduced the risk of heart damage among high-risk cancer patients treated with anthracycline chemotherapy agents.

Interim Phase 1 Update Shows Favorable Effect of Nex-z for ATTR-CM | Image Credit: Intellia
Interim Phase 1 Update Shows Favorable Effect of Nex-z for ATTR-CM

November 16th 2024

Walter McGregor, MD | Credit: Allegheny Health network
Vastly Improving Outcomes for Heart Valve Disease at Allegheny Health Network

October 4th 2024

Cardiology Month in Review: August 2024 | Image Credit: HCPLive
Cardiology Month in Review: August 2024

September 6th 2024

Deepak Bhatt, MD, MPH, MBA | Credit: Mount Sinai Heart
ESC Congress Recap: High-Impact Clinical Trials, with Deepak Bhatt, MD, MPH, MBA

September 5th 2024

<123
© 2024 MJH Life Sciences

All rights reserved.